Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes

Completed

Conditions studied: Kidney Transplant

In brief

Use of continuous glucose monitor (CGM) in post kidney transplant patients to better assess changes in glucose levels post kidney transplant

Key facts

Study ID

NCT07271433

Run by

The Cleveland Clinic

People needed

20

Starts

2024-01-29

Expected to finish

2026-01-01

Last updated by the study team

2026-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Sex: men and women
• Ethnicity: all ethnic groups
• Age: ≥ 18
• Known type 2 diabetes before kidney transplant
• Kidney transplant alone
• On multiple daily insulin injection
• Standard prednisone taper
• Smart phone - compatible with the LibreView App

You may not qualify if…

• Simultaneous pancreas-kidney transplant
• Allergy to Freestyle Libre components including adhesive
• Use of vitamin C at doses 500 mg or greater
• Blood dyscrasias that prevent hemoglobin A1c interpretation
• Lack of mobile app accessibility
• Rapid prednisone taper

Where it is running

• The Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.